Migraine drug scores double win

Posted 7 May 2025 PM

Teva Pharma’s prophylactic migraine treatment Ajovy could also help reduce symptoms of depression, a new international study published in JAMA Neurology has found.

The team of researchers led by the Albert Einstein College of Medicine in the US say that their UNITE study is the first-ever placebo-controlled, randomised clinical trial to demonstrate significant improvements in migraine and depressive symptoms with a single drug.

To see the whole article, please login